Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts

New England Journal of Medicine

Volumn 335, Issue 12, 1996, Pages 860-863

  Tydén, Gunnar ^a   Reinholt, Finn P ^a   Sundkvist, Göran ^b   Bolinder, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; FEMALE; GRAFT REJECTION; HUMANS; ISLETS OF LANGERHANS; MALE; PANCREAS; PANCREAS TRANSPLANTATION; RECURRENCE;

EID: 0029810878     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609193351205     Document Type: Article

References (11)

1. Eisenbarth GS. Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 1986;314:1360-8
2. Sutherland DER, Goetz FC, Sibley RK. Recurrence of disease in pancreas transplants, Diabetes 1989;38:Suppl 1:85-7.
3. Sibley RK, Sutherland DER. Pancreas transplantation: an immunohistologic and histopathologic examination of 100 grafts. Am J Pathol 1987; 128:151-70.
4. Tydén G, Brattström C, Lundgren G, Ostman J, Gunnarsson R, Groth CG. Improved results in pancreatic transplantation by avoidance of nonimmunological graft failures. Transplantation 1987;43:674-6.
5. Östman J, Bolinder I, Gunnarsson R, et al. Effects of pancreas transplantation on metabolic and hormonal profiles in IDDM patients. Diabetes 1989;38:Suppl 1:88-93.
6. Olsson ML, Sundkvist G, Lernmark A. Prolonged incubation in the two-colour immunofluorcscence test increases the prevalence and titres of islet cell antibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987;30:327-32.
7. Grubin CE, Daniels T, Toivola B, et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-spccific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-50.
8. Foulis AK, Liddle CN, Farquharson MA, Richmond JA, Weir RS. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 1986;29:267-74.
9. Gottsäter A, Landin-Olsson M, Ferniund P, Lernmark Å, Sundkvist G. Beta-cell function in relation to islet cell antibodies during the first 3 years after clinical diagnosis of diabetes in type II diabetic patients. Diabetes Care 1993;16:902-10.
10. Bosi E, Bottazzo GF, Secchi A, et al. Islet cell autoimmuniry in type 1 diabetic patients after HLA-mismatched pancreas transplantation. Diabetes 1989;38:Suppl 1:82-4.
11. Rakotoambinina B, Timsit J, Deschamps I, et al. Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients. Diabetes Care 1995;18:1487-90.